Detail Information of Exogenous Modulation
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0085 Transporter Info | ||||
Gene Name | SLC12A4 | ||||
Transporter Name | Electroneutral potassium-chloride cotransporter 1 | ||||
Gene ID | |||||
UniProt ID | |||||
Exogenous factors (drugs, dietary constituents, etc.) Modulation of This DT (EGM) | |||||
---|---|---|---|---|---|
Chemical Compound |
|||||
DT Modulation1 |
Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of SLC12A4 mRNA | [2] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation2 |
Coumestrol co-treated with Resveratrol results in increased expression of SLC12A4 mRNA | [2] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation1 |
Benzo(a)pyrene affects the methylation of SLC12A4 exon | [23] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation2 |
Benzo(a)pyrene results in increased methylation of SLC12A4 promoter | [23] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
1-Methyl-4-phenylpyridinium |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
1-Methyl-4-phenylpyridinium results in increased expression of SLC12A4 mRNA | [14] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
2,3-bis(3'-hydroxybenzyl)butyrolactone |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of SLC12A4 mRNA | [2] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
6,7-dimethoxy-2-(pyrrolidin-1-yl)-N-(5-(pyrrolidin-1-yl)pentyl)quinazolin-4-amine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
6,7-dimethoxy-2-(pyrrolidin-1-yl)-N-(5-(pyrrolidin-1-yl)pentyl)quinazolin-4-amine results in increased expression of SLC12A4 mRNA | [20] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
abrine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
abrine results in increased expression of SLC12A4 mRNA | [21] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
bisphenol B |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
bisphenol B results in increased expression of SLC12A4 protein | [19] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
bisphenol F |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
bisphenol F results in increased expression of SLC12A4 protein | [19] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
di-n-butylphosphoric acid |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
di-n-butylphosphoric acid affects the expression of SLC12A4 mRNA | [25] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
FR900359 |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
FR900359 affects the phosphorylation of SLC12A4 protein | [26] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
K 7174 |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
K 7174 results in increased expression of SLC12A4 mRNA | [13] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Manganese |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
sodium arsenite results in increased abundance of Arsenic co-treated with manganese chloride results in increased abundance of Manganese results in decreased expression of SLC12A4 mRNA | [22] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
manganese chloride |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
sodium arsenite results in increased abundance of Arsenic co-treated with manganese chloride results in increased abundance of Manganese results in decreased expression of SLC12A4 mRNA | [22] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Ozone |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Air Pollutants results in increased abundance of Ozone which affects the expression of SLC12A4 mRNA | [27] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
sodium arsenite |
3 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
sodium arsenite results in increased abundance of Arsenic co-treated with manganese chloride results in increased abundance of Manganese results in decreased expression of SLC12A4 mRNA | [22] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation2 |
sodium arsenite results in increased abundance of Arsenic which results in decreased expression of SLC12A4 mRNA | [22] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation3 |
sodium arsenite results in increased expression of SLC12A4 mRNA | [28] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Thiram |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Thiram results in increased expression of SLC12A4 mRNA | [28] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
triphenyl phosphate |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
triphenyl phosphate affects the expression of SLC12A4 mRNA | [25] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Valproic Acid |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Valproic Acid results in increased methylation of SLC12A4 gene | [29] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Vanadates |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Vanadates results in increased expression of SLC12A4 mRNA | [30] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Approved Drug |
|||||
Decitabine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Decitabine increases the expression of SLC12A4 | [1] | |||
Estradiol |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Estradiol increases the expression of SLC12A4 | [2] | |||
Tretinoin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Tretinoin increases the expression of SLC12A4 | [3] | |||
Zidovudine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Zidovudine increases the expression of SLC12A4 | [4] | |||
Leflunomide |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Leflunomide increases the expression of SLC12A4 | [5] | |||
Doxorubicin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Doxorubicin increases the expression of SLC12A4 | [6] | |||
Dactinomycin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Dactinomycin induces the activity of SLC12A4 | [8] | |||
Drug Marketed but not Approved by US FDA |
|||||
Rotenone |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Rotenone increases the expression of SLC12A4 | [7] | |||
Drug in Phase 3 Trial |
|||||
Resveratrol |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Resveratrol increases the expression of SLC12A4 | [15] | |||
Drug in Phase 2 Trial |
|||||
Genistein |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Genistein inhibits the expression of SLC12A4 | [9] | |||
Bisphenol B |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Bisphenol B increases the expression of SLC12A4 | [19] | |||
Drug in Phase 1 Trial |
|||||
Quercetin |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Quercetin increases the expression of SLC12A4 | [12] | |||
Investigative Drug |
|||||
Coumestrol |
3 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Coumestrol increases the expression of SLC12A4 | [2] | |||
Patented Pharmaceutical Agent |
|||||
K-7174 |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
K-7174 increases the expression of SLC12A4 | [13] | |||
Natural Product |
|||||
Coal Ash |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Coal Ash increases the expression of SLC12A4 | [11] | |||
DT Modulation1 |
Quercetin results in increased phosphorylation of SLC12A4 protein | [24] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation1 |
Coumestrol co-treated with Resveratrol results in increased expression of SLC12A4 mRNA | [2] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Caffeine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Caffeine results in decreased phosphorylation of SLC12A4 protein | [24] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Environmental toxicant |
|||||
Zinc |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Zinc increases the expression of SLC12A4 | [10] | |||
Bisphenol F |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Bisphenol F increases the expression of SLC12A4 | [19] | |||
Acute Toxic Substance |
|||||
Acrylamide |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Acrylamide inhibits the expression of SLC12A4 | [18] | |||
Carcinogen |
|||||
Benzo(a)pyrene |
3 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Benzo(a)pyrene increases the expression of SLC12A4 | [17] | |||
Arsenic |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
sodium arsenite results in increased abundance of Arsenic co-treated with manganese chloride results in increased abundance of Manganese results in decreased expression of SLC12A4 mRNA | [22] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation2 |
sodium arsenite results in increased abundance of Arsenic which results in decreased expression of SLC12A4 mRNA | [22] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Health and Environmental Toxicant |
|||||
1-methyl-4-phenylpyridinium |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
1-methyl-4-phenylpyridinium increases the expression of SLC12A4 | [14] | |||
Lead |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Lead affects the expression of SLC12A4 | [16] | |||
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.